X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (179) 179
Book Review (8) 8
Dissertation (2) 2
Journal / eJournal (2) 2
Reference (2) 2
Book / eBook (1) 1
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (100) 100
female (67) 67
male (63) 63
adult (50) 50
physiology (42) 42
middle aged (31) 31
neurosciences (28) 28
research (24) 24
aged (19) 19
blood pressure (18) 18
exercise (18) 18
young adult (17) 17
analysis (16) 16
animals (16) 16
health aspects (16) 16
adolescent (15) 15
blood pressure - drug effects (15) 15
blood-pressure (15) 15
regional blood flow - physiology (15) 15
risk factors (15) 15
forearm - blood supply (14) 14
sport sciences (14) 14
blood pressure - physiology (13) 13
hypertension (13) 13
studies (13) 13
abridged index medicus (12) 12
education (12) 12
exercise - physiology (12) 12
medicine & public health (12) 12
vasodilation - physiology (12) 12
age (11) 11
medical research (11) 11
sympathetic nervous system - physiology (11) 11
clinical neurology (10) 10
hyperemia - physiopathology (10) 10
nitric oxide - physiology (10) 10
regional blood flow - drug effects (10) 10
united states (10) 10
diabetes (9) 9
endocrinology (9) 9
neurology (9) 9
nitric oxide (9) 9
nitric-oxide (9) 9
physiological aspects (9) 9
research article (9) 9
skeletal-muscle (9) 9
baroreflex - physiology (8) 8
blood flow (8) 8
blood-flow (8) 8
cardiology (8) 8
drug therapy (8) 8
endocrinology & metabolism (8) 8
medicine (8) 8
medicine, general & internal (8) 8
multidisciplinary sciences (8) 8
ophthalmology (8) 8
original research (8) 8
postmenopausal women (8) 8
risk (8) 8
sympathetic-nerve activity (8) 8
time factors (8) 8
vasodilation (8) 8
women (8) 8
cardiac & cardiovascular systems (7) 7
care and treatment (7) 7
forearm (7) 7
forearm - physiology (7) 7
gastroenterology (7) 7
gender (7) 7
health (7) 7
methods (7) 7
sleep (7) 7
surgery (7) 7
vasodilation - drug effects (7) 7
aged, 80 and over (6) 6
aging (6) 6
aspirin (6) 6
autonomic nervous system (6) 6
baroreflex sensitivity (6) 6
cardiac arrhythmia (6) 6
communication (6) 6
education, scientific disciplines (6) 6
gene expression (6) 6
genetic aspects (6) 6
heart beat (6) 6
heart rate (6) 6
heart rate - drug effects (6) 6
heart rate - physiology (6) 6
hemodynamics - physiology (6) 6
hemorrhage (6) 6
hyperemia (6) 6
hypoxia (6) 6
management (6) 6
medicine, experimental (6) 6
mortality (6) 6
muscle, skeletal - innervation (6) 6
muscle, skeletal - physiology (6) 6
pharmacology & pharmacy (6) 6
respiratory system (6) 6
responses (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SAE technical paper series, Volume 760843.
The driveline in a truck can be the source of vibrations. This paper explains and gives corrective procedures for driveline vibrations caused by unbalance,... 
Vibration | Noise
eJournal
SAE technical paper series, Volume 780778.
The driveline in an application can be the source of vibrations. This paper explains and gives corrective procedures for driveline vibrations caused by... 
Universal joints
eJournal
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 20, pp. 2066 - 2078
A randomized trial enrolled 7554 patients with atrial fibrillation who were at increased risk of stroke but not candidates for vitamin K antagonists.... 
STROKE | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | ORAL ANTICOAGULATION | WARFARIN | ANTITHROMBOTIC THERAPY | THROMBOGENESIS | VASCULAR EVENTS | RISK | ACUTE CORONARY SYNDROMES | PLATELET ACTIVATION | Myocardial Infarction - epidemiology | Follow-Up Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Risk | Incidence | Vascular Diseases - mortality | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Embolism - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Ticlopidine - analogs & derivatives | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Evaluation | Complications and side effects | Aspirin | Atrial fibrillation | Clopidogrel | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Medical research | Stroke | Mortality | Data collection | Cardiovascular disease | Acute coronary syndromes | Index Medicus | Abridged Index Medicus | Bioengineering | Life Sciences | Vascular Diseases | Computer Science | Atrial Fibrillation | Vitamin K | Embolism | Ticlopidine | Signal and Image processing | Myocardial Infarction | Platelet Aggregation Inhibitors | Engineering Sciences
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 9, pp. 806 - 817
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 12, pp. 1139 - 1151
Journal Article
by Rimol, L. M and Agartz, I and Djurovic, S and Brown, A. A and Roddey, J. C and Kahler, A. K and Mattingsdal, M and Athanasiu, L and Joyner, A. H and Schork, N. J and Halgren, E and Sundet, K and Melle, I and Dale, A. M and Andreassen, O. A and Weiner, M and Thal, L and Petersen, R and Jack, C. R and Jagust, W and Trojanowki, J and Toga, A. W and Beckett, L and Green, R. C and Gamst, A and Potter, W. Z and Montine, T and Anders, D and Bernstein, M and Felmlee, J and Fox, N and Thompson, P and Schuff, N and Alexander, G and Bandy, D and Koeppe, R. A and Foster, N and Reiman, E. M and Chen, K and Shaw, L and Lee, V. M.- Y and Korecka, M and Crawford, K and Neu, S and Harvey, D and Kornak, J and Kachaturian, Z and Frank, R and Snyder, P. J and Molchan, S and Kaye, J and Vorobik, R and Quinn, J and Schneider, L and Pawluczyk, S and Spann, B and Fleisher, A. S and Vanderswag, H and Heidebrink, J. L and Lord, J. L and Johnson, K and Doody, R. S and Villanueva-Meyer, J and Chowdhury, M and Stern, Y and Honig, L. S and Bell, K. L and Morris, J. C and Mintun, M. A and Schneider, S and Marson, D and Griffith, R and Badger, B and Grossman, H and Tang, C and Stern, J and deToledo-Morrell, L and Shah, R. C and Bach, J and Duara, R and Isaacson, R and Strauman, S and Albert, M. S and Pedroso, J and Toroney, J and Rusinek, H and de Leon, M. J and De Santi, S. M and Doraiswamy, P. M and Petrella, J. R and Aiello, M and Clark, C. M and Pham, C and Nunez, J and Smith, C. D and Given II, C. A and Hardy, P and DeKosky, S. T and Oakley, M and Simpson, D. M and ... and for the Alzheimer's Disease Neuroimaging Initiative and Alzheimers Dis Neuroimaging Initia and Alzheimer's Disease Neuroimaging Initiative
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2009, Volume 107, Issue 1, pp. 384 - 388
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 23, pp. 2191 - 2201
In a randomized trial involving patients who had a first stroke from an embolus of unknown source, rivaroxaban at a daily dose of 15 mg did not result in a... 
CRYPTOGENIC STROKE | TRIALS | MEDICINE, GENERAL & INTERNAL | DESIGN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | ANTITHROMBOTIC THERAPY | FORAMEN OVALE CLOSURE | ATRIAL-FIBRILLATION | Stroke - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Brain Ischemia - prevention & control | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Intracranial Embolism - drug therapy | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke (Disease) | Prevention | Rivaroxaban | Complications and side effects | Dosage and administration | Drug therapy | Hemorrhage | Risk factors | Cardiac arrhythmia | Neurosciences | Embolisms | Stenosis | Bleeding | Design | Ischemia | Atherosclerosis | Drug dosages | Research centers | Anticoagulants | Medical research | Stroke | Aspirin | Internal medicine | Research & development--R&D | Thrombosis | Patients | Embolism | Blood clots | Medicine | Neurology | Hospitals | Life Sciences | Human health and pathology | metaanalysis | atrial-fibrillation | foramen ovale closure | antithrombotic therapy | Klinisk medicin | efficacy | warfarin | Clinical Medicine | trials | safety | design | cryptogenic stroke | General & Internal Medicine
Journal Article